Text Size A A A


***IMPORTANT NOTICE - RAN™-VALSARTAN was not affected by the Health Canada recall on July 9, 2018.***

Sun Pharma entered the Canadian market in 2015 with the purchase of Ranbaxy Laboratories Limited, a Top 10 generic company in Canada since 2005. Sun Pharma is a world leader in specialty generics and we are now well positioned to be an even larger contributor to the Canadian healthcare landscape.

With global manufacturing across six continents we are investing in Canada by bringing high quality, affordable and innovative generic medicines to market. Our global strength in R&D with an unwavering commitment to quality ensures Sun Pharma will offer a wide range of affordable medicines for Canadians.

Over the coming months you will see the Ranbaxy labelled products transition to the Sun label. With this transition only the prefix will change, RAN will become SUN. Wherever possible, as we implement the label change, the product markings, formulations, DINs and UPC numbers will remain the same. It is our hope that this approach will minimize any inconvenience to our customers.

We look forward to many more years of providing Canadians with high quality and affordable medicines.

Detailed product information is available online to Pharmacists, please click here